• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者结直肠狭窄进展为结直肠肿瘤的风险和发生率:系统评价和荟萃分析。

Risk and incidence of colorectal stricture progressing to colorectal neoplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis.

机构信息

Shaanxi University of Chinese Medicine, Xianyang.

Ankang Hospital of Traditional Chinese Medicine, Ankang.

出版信息

Eur J Gastroenterol Hepatol. 2023 Oct 1;35(10):1075-1087. doi: 10.1097/MEG.0000000000002614. Epub 2023 Jul 31.

DOI:10.1097/MEG.0000000000002614
PMID:37577790
Abstract

This study aims to assess the risk of colorectal stricture progressing to colorectal neoplasia (CRN) in patients with inflammatory bowel disease (IBD). The literature from PubMed, Embase, Web of Science, and Cochrane Library databases was searched from the date of databases' creation to 5 November 2022. The Newcastle-Ottawa Scale was used to evaluate the quality of the included literature. Meta-analysis was conducted using the Stata 15 software and R 4.04 software. Two case-control studies and 12 cohort studies were eventually included. Colorectal stricture in patients with IBD increased the risk of progressing to CRN [odds ratio (OR): 1.52, 95% confidence interval (CI): 1.02-2.29, P = 0.042], but was irrelevant to the risk of progressing to ACRN (OR: 3.56, 95% CI 0.56-22.70, P = 0.180). The risk of CRN were further distinguished in patients with ulcerative colitis (UC) and Crohn's disease (CD) Our findings showed that colorectal stricture may increase the risk of progressing to CRN in patients with UC (OR = 3.53, 95%CI 1.62-7.68, P = 0.001), but was irrelevant to the risk of progressing to CRN in patients with CD (OR = 1.09, 95% CI 0.54-2.21, P = 0.811). In conclusion, colorectal stricture in patients with IBD can be used as a risk factor for predicting CRN but cannot be used as a risk factor for predicting ACRN. Stricture is a risk factor for CRN in patients with UC but not in patients with CD. More prospective, multi-center studies with large samples are expected to confirm our findings.

摘要

本研究旨在评估炎症性肠病(IBD)患者结直肠狭窄进展为结直肠肿瘤(CRN)的风险。从数据库创建日期到 2022 年 11 月 5 日,检索了 PubMed、Embase、Web of Science 和 Cochrane Library 数据库中的文献。使用纽卡斯尔-渥太华量表评估纳入文献的质量。使用 Stata 15 软件和 R 4.04 软件进行荟萃分析。最终纳入了 2 项病例对照研究和 12 项队列研究。IBD 患者的结直肠狭窄增加了进展为 CRN 的风险[比值比(OR):1.52,95%置信区间(CI):1.02-2.29,P = 0.042],但与进展为 ACRN 的风险无关(OR:3.56,95%CI 0.56-22.70,P = 0.180)。在溃疡性结肠炎(UC)和克罗恩病(CD)患者中进一步区分了 CRN 的风险。我们的研究结果表明,结直肠狭窄可能会增加 UC 患者进展为 CRN 的风险(OR = 3.53,95%CI 1.62-7.68,P = 0.001),但与 CD 患者进展为 CRN 的风险无关(OR = 1.09,95%CI 0.54-2.21,P = 0.811)。总之,IBD 患者的结直肠狭窄可作为预测 CRN 的危险因素,但不能作为预测 ACRN 的危险因素。狭窄是 UC 患者 CRN 的危险因素,但不是 CD 患者 CRN 的危险因素。预计将开展更多前瞻性、多中心、大样本研究来证实我们的研究结果。

相似文献

1
Risk and incidence of colorectal stricture progressing to colorectal neoplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis.炎症性肠病患者结直肠狭窄进展为结直肠肿瘤的风险和发生率:系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2023 Oct 1;35(10):1075-1087. doi: 10.1097/MEG.0000000000002614. Epub 2023 Jul 31.
2
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
3
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
4
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
5
Strategies for detecting colon cancer in patients with inflammatory bowel disease.炎症性肠病患者结肠癌的检测策略。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.
6
Helminth therapy (worms) for induction of remission in inflammatory bowel disease.蠕虫疗法(使用蠕虫)诱导炎症性肠病缓解
Cochrane Database Syst Rev. 2014 Jan 20;2014(1):CD009400. doi: 10.1002/14651858.CD009400.pub2.
7
Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale.炎症性肠病患者代谢综合征的患病率:一项全球范围的荟萃分析
J Health Popul Nutr. 2025 Apr 9;44(1):112. doi: 10.1186/s41043-025-00860-z.
8
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
9
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.用于治疗炎症性肠病风湿性表现的选择性环氧化酶2抑制剂的耐受性
Cochrane Database Syst Rev. 2014 Oct 23;2014(10):CD007744. doi: 10.1002/14651858.CD007744.pub2.
10
Ischemic Stroke May Increase the Risk of Crohn's Disease and Ulcerative Colitis: Evidence from a Bidirectional Mendelian Randomization Study.缺血性中风可能增加克罗恩病和溃疡性结肠炎的风险:来自双向孟德尔随机化研究的证据。
World Neurosurg. 2025 Apr;196:123718. doi: 10.1016/j.wneu.2025.123718. Epub 2025 Mar 13.

引用本文的文献

1
Risk factors and long-term prognosis for colorectal strictures in ulcerative colitis.溃疡性结肠炎患者大肠狭窄的危险因素及长期预后
World J Gastroenterol. 2025 Sep 7;31(33):109938. doi: 10.3748/wjg.v31.i33.109938.
2
Severe Rectal Stenosis as the First Clinical Appearance of a Metastasis Originating from the Bladder: A Case Report and Literature Review.严重直肠狭窄作为膀胱转移瘤的首发临床表现:一例报告及文献复习
Life (Basel). 2025 Apr 22;15(5):682. doi: 10.3390/life15050682.
3
Genomic characterization of Escherichia coli with a polyketide synthase (pks) island isolated from ulcerative colitis patients.
从溃疡性结肠炎患者中分离出的具有聚酮合酶(pks)岛的大肠杆菌的基因组特征分析
BMC Genomics. 2025 Jan 8;26(1):19. doi: 10.1186/s12864-024-11198-x.